life-liver.co.kr
Contact us
About company
LifeLiver rights to cell therapies HepaStem and H2Stem to treat liver diseases in South Korea. The companies will jointly develop the products to treat non-alcoholic steatohepatitis (NASH) and acute-on-chronic liver failure (ACLF), and...
KR
Unknown
Unknown
Not verified company
